These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21699209)

  • 1. Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.
    Ramnauth J; Speed J; Maddaford SP; Dove P; Annedi SC; Renton P; Rakhit S; Andrews J; Silverman S; Mladenova G; Zinghini S; Nair S; Catalano C; Lee DK; De Felice M; Porreca F
    J Med Chem; 2011 Aug; 54(15):5562-75. PubMed ID: 21699209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors.
    Annedi SC; Maddaford SP; Ramnauth J; Renton P; Speed J; Rakhit S; Andrews JS; Porreca F
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1980-4. PubMed ID: 22318159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.
    Ramnauth J; Renton P; Dove P; Annedi SC; Speed J; Silverman S; Mladenova G; Maddaford SP; Zinghini S; Rakhit S; Andrews J; Lee DK; Zhang D; Porreca F
    J Med Chem; 2012 Mar; 55(6):2882-93. PubMed ID: 22335555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.
    Annedi SC; Maddaford SP; Ramnauth J; Renton P; Rybak T; Silverman S; Rakhit S; Mladenova G; Dove P; Andrews JS; Zhang D; Porreca F
    Eur J Med Chem; 2012 Sep; 55():94-107. PubMed ID: 22840695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.
    Annedi SC; Ramnauth J; Maddaford SP; Renton P; Rakhit S; Mladenova G; Dove P; Silverman S; Andrews JS; Felice MD; Porreca F
    J Med Chem; 2012 Jan; 55(2):943-55. PubMed ID: 22175766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain.
    Annedi SC; Maddaford SP; Mladenova G; Ramnauth J; Rakhit S; Andrews JS; Lee DK; Zhang D; Porreca F; Bunton D; Christie L
    J Med Chem; 2011 Oct; 54(20):7408-16. PubMed ID: 21923116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.
    Mladenova G; Annedi SC; Ramnauth J; Maddaford SP; Rakhit S; Andrews JS; Zhang D; Porreca F
    J Med Chem; 2012 Apr; 55(7):3488-501. PubMed ID: 22420844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).
    Annedi SC; Ramnauth J; Cossette M; Maddaford SP; Dove P; Rakhit S; Andrews JS; Porreca F
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2510-3. PubMed ID: 22370270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice.
    Guan Y; Yaster M; Raja SN; Tao YX
    Mol Pain; 2007 Oct; 3():29. PubMed ID: 17922909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
    Lee WH; Carey LM; Li LL; Xu Z; Lai YY; Courtney MJ; Hohmann AG
    Mol Pain; 2018; 14():1744806918801224. PubMed ID: 30157705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dexmedetomidine on expression of neuronal nitric oxide synthase in spinal dorsal cord in a rat model with chronic neuropathic pain.
    Pang J; Zhang S; Kong Y; Wang Z; Pei R; Zhuang P; Wang X
    Arq Neuropsiquiatr; 2023 Mar; 81(3):233-239. PubMed ID: 37059432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.
    Payne JE; Bonnefous C; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
    J Med Chem; 2010 Nov; 53(21):7739-55. PubMed ID: 20931971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development.
    Luo ZD; Chaplan SR; Scott BP; Cizkova D; Calcutt NA; Yaksh TL
    J Neurosci; 1999 Nov; 19(21):9201-8. PubMed ID: 10531423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of neuronal nitric oxide synthase in the periphery promotes pain hypersensitivity after peripheral nerve injury.
    Kim KH; Kim JI; Han JA; Choe MA; Ahn JH
    Neuroscience; 2011 Sep; 190():367-78. PubMed ID: 21664432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury.
    Chen SR; Jin XG; Pan HL
    Neuropharmacology; 2017 Oct; 125():156-165. PubMed ID: 28754372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective inhibition of nNOS and iNOS on neuropathic pain in rats.
    Rocha PA; Ferreira AFB; Da Silva JT; Alves AS; Martins DO; Britto LRG; Chacur M
    Mol Cell Neurosci; 2020 Jun; 105():103497. PubMed ID: 32353527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response.
    Lin J; Zhang X; Li C; Zhang Y; Lu H; Chen J; Li Z; Yang X; Wu Z
    J Ethnopharmacol; 2020 May; 254():112727. PubMed ID: 32147481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model.
    Choi JI; Kim WM; Lee HG; Kim YO; Yoon MH
    Neurosci Lett; 2012 Feb; 510(1):53-7. PubMed ID: 22249118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn.
    Cízková D; Lukácová N; Marsala M; Marsala J
    Brain Res Bull; 2002 Jun; 58(2):161-71. PubMed ID: 12127013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide signaling contributes to ectopic orofacial neuropathic pain.
    Sugiyama T; Shinoda M; Watase T; Honda K; Ito R; Kaji K; Urata K; Lee J; Ohara K; Takahashi O; Echizenya S; Iwata K
    J Dent Res; 2013 Dec; 92(12):1113-7. PubMed ID: 24130220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.